Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-56.61	18.19	41.93
Graham Fair Price	-23.25	16735.80	21806.87
PEG	93.34	-0.22	-3.33
Price/Book	-7.06	0.84	0.90
Price/Cash Flow	-132.46	-26.63	-11.46
Prices/Earnings	75.65	9.78	5.57
Price/Sales	-1.24	1.86	1.88
Price/FCF	-132.46	-26.63	-11.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	12.11	0.52	0.47
Operating Margin	242.57	0.11	0.03
ROA	-46.60	< 0.005	0.02
ROE	0.04	0.02	-47.09
ROIC	0.02	0.03	45.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.14	-44.85
Dividends QOQ	-0.80	-1.00	-24.82
EBIT QOQ	-0.78	2.40	206.83
EPS QOQ	-0.02	-0.44	-2538.77
FCF QOQ	-6.10	0.58	-90.53
Revenue QOQ	-0.03	< 0.005	77.29
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	133.01	157.47	18.39
Days Sales Outstanding (DSO)	45.81	42.54	-7.14
Inventory Turnover	0.68	0.57	-15.53
Debt/Capitalization	0.34	0.34	1.27
Quick Ratio	0.72	0.65	-9.11
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22860.84	24119.17	5.50
Cash	6533.60	6493.81	-0.61
Capex	-2614.47	-1693.79	35.21
Free Cash Flow	-1798.30	-758.59	57.82
Revenue	10932.68	10854.81	-0.71
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.25	1.19	-4.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.43	4.93	-56.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating